Keith Faucher

Company: Aura Biosciences

Job title: Sr. Director Device Development & Innovation

Seminars:

Understanding the Evolving Extractables & Leachables (E&L) Regulatory Expectations to Circumvent Drug Product Approval Delays 12:30 pm

Highlighting potential drug-device interactions early on in development to reduce risk and achieve the best possible outcome Exploring E&L testing and analysis to quantify and assess risks associated with leachable impurities Reviewing regulatory requirements within Extractable & Leachable testing for combination productsRead more

day: Day One